VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HIMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HIMSHims & Hers Health, Inc.
$33.39$7.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHIMSQuarterly Financials

Hims & Hers Health, Inc. (HIMS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Hims & Hers Health, Inc. (HIMS) quarterly income statement — complete revenue, gross profit & net income history

HIMS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue608.1M617.82M598.98M544.83M586.01M481.14M401.56M315.65M278.17M246.62M226.7M207.91M
Revenue Growth %3.77%28.41%49.16%72.61%110.67%95.09%77.13%51.82%45.81%47.5%56.52%83.08%
Cost of Goods Sold307.82M173.38M156.92M128.64M155.32M111.6M83.67M59.03M49.08M42.56M39.39M37.75M
COGS % of Revenue50.62%28.06%26.2%23.61%26.5%23.19%20.84%18.7%17.64%17.26%17.38%18.16%
Gross Profit300.28M444.44M442.06M416.2M430.69M369.54M317.89M256.61M229.09M204.06M187.31M170.16M
Gross Margin %49.38%71.94%73.8%76.39%73.5%76.81%79.16%81.3%82.36%82.74%82.62%81.84%
Gross Profit Growth %-30.28%20.27%39.06%62.19%88%81.1%69.71%50.81%49.32%54.2%63.65%95.19%
Operating Expenses316.75M435.25M430.25M389.47M372.79M350.94M295.51M245.58M219.19M204.46M195.86M179.39M
OpEx % of Revenue52.09%70.45%71.83%71.48%63.62%72.94%73.59%77.8%78.8%82.9%86.4%86.28%
Selling, General & Admin331.67M314.21M312.83M285.13M279.85M269.11M226.9M185.48M165.12M158.21M151.98M138.36M
SG&A % of Revenue54.54%50.86%52.23%52.33%47.75%55.93%56.51%58.76%59.36%64.15%67.04%66.55%
Research & Development46.94M40.96M40.58M37.85M29.91M23.75M21.09M18.65M15.32M13.4M12.27M11.8M
R&D % of Revenue7.72%6.63%6.77%6.95%5.1%4.94%5.25%5.91%5.51%5.44%5.41%5.68%
Other Operating Expenses-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income-16.47M9.19M11.81M26.72M57.9M18.6M22.37M11.03M9.9M-400K-8.55M-9.24M
Operating Margin %-2.71%1.49%1.97%4.9%9.88%3.86%5.57%3.49%3.56%-0.16%-3.77%-4.44%
Operating Income Growth %-128.45%-50.6%-47.23%142.28%484.64%4749%361.56%219.42%187.93%96.55%57.19%54.25%
EBITDA5.48M27.28M29.48M37.19M66.17M24.66M26.76M14.67M12.9M2.26M-6.19M-6.86M
EBITDA Margin %0.9%4.42%4.92%6.83%11.29%5.12%6.66%4.65%4.64%0.92%-2.73%-3.3%
EBITDA Growth %-91.71%10.63%10.16%153.45%412.81%991.98%532.19%313.92%241.09%123.53%65.76%62.66%
D&A (Non-Cash Add-back)21.95M18.09M17.67M10.46M8.28M6.06M4.38M3.64M3M2.66M2.36M2.38M
EBIT-16.47M9.19M12.22M26.72M57.9M18.6M22.37M11.03M9.9M-400K-8.55M-9.24M
Net Interest Income000000000000
Interest Income000000000000
Interest Expense000000000000
Other Income/Expense-85.08M9.17M416K6.13M2.6M3.69M1.22M2.39M2.5M2.6M1.64M2.07M
Pretax Income-101.55M18.35M12.22M32.85M60.49M22.29M23.59M13.42M12.4M2.2M-6.92M-7.17M
Pretax Margin %-16.7%2.97%2.04%6.03%10.32%4.63%5.88%4.25%4.46%0.89%-3.05%-3.45%
Income Tax-9.44M-2.25M-3.55M-9.65M11.01M-3.73M-51.99M127K1.27M951K651K-13K
Effective Tax Rate %9.29%-12.25%-29.05%-29.38%18.2%-16.75%-220.38%0.95%10.28%43.31%-9.41%0.18%
Net Income-92.11M20.6M15.77M42.51M49.48M26.02M75.59M13.3M11.13M1.25M-7.57M-7.16M
Net Margin %-15.15%3.33%2.63%7.8%8.44%5.41%18.82%4.21%4%0.5%-3.34%-3.44%
Net Income Growth %-286.15%-20.84%-79.13%219.66%344.69%1990.36%1098.92%285.79%210.54%111.41%59.84%63.63%
Net Income (Continuing)-92.11M20.6M15.77M42.51M49.48M26.02M75.59M13.3M11.13M1.25M-7.57M-7.16M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.400.080.060.170.200.110.320.060.050.01-0.04-0.03
EPS Growth %-300%-27.27%-80.19%200.35%300%-988.89%265.01%202.88%111.15%60.78%64.46%
EPS (Basic)-0.400.090.070.190.220.120.350.060.050.01-0.04-0.03
Diluted Shares Outstanding228.36M248.1M248.68M256.78M246.61M240.73M235.07M234.79M229.36M209.74M210.13M208.42M
Basic Shares Outstanding228.36M227.06M226.35M224.37M221.99M219.03M216.62M214.62M213.45M209.74M210.13M208.42M
Dividend Payout Ratio------------